High Cost of Sovaldi Hepatitis C Drug Prompts a Call to Void Its Patents
Gilead denied patent for hepatitis C drug sofosbuvir in India
India rejects Gilead’s Hepatitis C drug patent request
Indian health activists move to prevent Gilead’s drug patent
US group seeks to block Gilead drug patent in India
Hepatitis C drug: US group opposes Gilead’s patent request in India
Gilead attempt to secure patent on hepatitis C drug opposed in India
Treatment Advocates Challenge Patent for New Hepatitis C Drug
Gilead Sciences’ Indian patent request for hepatitis C drug sofosbuvir faces opposition
US group seeks block on blockbuster Hep-C drug patent in India